FITAKH

Palmitoyl Tetrapeptide-7

Palmitoyl Tetrapeptide-7

Palmitoyl Tetrapeptide-7 (Calming, Stabilizing, and Repairing Ingredient)

Product Overview

Palmitoyl Tetrapeptide-7 is a highly adaptable lipophilic bioactive peptide prepared by precise bionic polypeptide synthesis technology, featuring stable molecular structure and excellent biocompatibility. Focusing on skin soothing and stabilization, it relieves skin stress response and improves skin condition, gently conditioning fragile skin base and alleviating skin intolerance, roughness and dullness. Mild and safe, it is suitable for formula R&D of medical-grade products for sensitive skin, seasonal fragile skin, post-procedure skin stabilization and early aging skin care. It can be flexibly compounded with bioactive peptides, recombinant collagen, hyaluronic acid, PDRN and regenerative microspheres to build a mild skin steady-state care system.

Core Customizable Technology

Customizable Activity Concentration: Gradient activity content can be customized to adapt to two formula systems: basic skin soothing stabilization and advanced deep repair conditioning, covering daily mild care and high-end repair product lines.

Customizable Compounding Ratio: Fully compatible with GHK-Cu, Palmitoyl Pentapeptide-4, Acetyl Hexapeptide-8, recombinant collagen, HA and polyester microspheres. Flexible proportion adjustment adapts to multiple dosage forms including soothing essence, repair lyophilized powder and barrier care dressings.

Lipophilic Activity Locking Process: Precise lipid modification combined with low-temperature vacuum purification stabilizes the active molecular structure, preventing oxidation and activity attenuation, and adapting to various industrial production processes such as liquid preparation, freeze-drying and cream filling.

Hierarchical Penetration Technology: The lipophilic small-molecule structure achieves superficial soothing and middle-layer basal conditioning with mild penetration, suitable for refined care formulas for sensitive and post-procedure fragile skin.

Working Mechanism

With excellent skin-friendly penetration, Palmitoyl Tetrapeptide-7 acts on the superficial and basal skin, gently regulating skin metabolism, relieving dryness, redness, sensitivity and other stress discomforts, and strengthening fragile cuticle barrier. It stabilizes the skin microenvironment for a long time, reduces external irritation damage, improves rough and dull skin texture, and maintains delicate, clear and healthy skin condition with continuous care.

Core Advantages

High-purity lipophilic bionic active peptide with no irritating impurities and mild properties, specially adapted for fragile, sensitive and post-procedure skin care with wide audience coverage.

Fully customizable concentration and blending ratio supports full-line product development from basic soothing stabilization to high-end barrier repair for brands.

Stable molecular structure with excellent storage resistance and compound compatibility, ensuring uniform batch quality and reducing formula debugging and production loss costs of end-products.

Complete COA inspection reports, biocompatibility tests and compliance filing documents support R&D and registration of Class II repair dressings and sensitive skin care medical-grade products.

Application Scenarios

For Brand OEM: Supply raw materials for sensitive-skin soothing essence, post-procedure skin stabilizing lyophilized powder and barrier repair conditioning dressing OEM substrates.

For Aesthetic Clinic Supporting: Raw materials for mild post-procedure skin repair and stabilization, seasonal redness and sensitivity relief, and refined conditioning for fragile skin.

Channel Supply: Raw materials for exclusive sensitive-skin repair kits, mild medical-grade skin care products, and cross-border bulk export of low-irritation bioactive peptide materials.

Disclaimer

Feitah only develops and sells medical biomaterials, and does not manufacture or sell finished medical devices. Partners shall independently complete R&D, processing and qualification registration of end-products. All end-products must obtain valid compliance certificates before market launch. All content herein objectively describes physical, chemical and biological properties of raw materials and does not constitute efficacy claims of any finished products.